Loading stock data…
Xylem Inc. (XYL)
$108.81+3.12 (+2.95%)
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Xylem Inc. in the Industrials sector is trading at $108.81 with a market capitalization of $28.1B. Wall Street consensus targets $153.88 (16 analysts), implying a +41.4% move over the next 12 months. The stock is currently near its 52-week low of $105.29, remaining 11.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +41.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.34B↑ | $2.13B↓ | $2.40B↑ | $2.27B↓ | $2.30B |
| Gross Profit | $963.00M↑ | $803.00M↓ | $932.00M↑ | $883.00M↓ | $892.00M |
| Operating Income | $401.00M↑ | $275.00M↓ | $386.00M↑ | $357.00M↑ | $331.00M |
| Net Income | $263.00M↑ | $193.00M↓ | $335.00M↑ | $227.00M↑ | $226.00M |
Peer Comparison
Fundamentals
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$28.09B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
28.65
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.01
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.53%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.77%
Volume
Today's trading volume
3.61M
Recent News
Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GE HealthCare Technologies (GEHC) Names A New CFO As Its Undervalued Narrative Faces A Test
GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing William K. Grogan as its incoming Chief Financial Officer, effective September 14, 2026, following his finance leadership roles at Xylem and IDEX. For investors watching GE HealthCare Technologies, the recent CFO news comes after a strong 30 day share price return of 22% and a 90 day share price return of 15.7%. However, the year to date share price return is down 10.76%, and the 1 year total shareholder return is...
Xylem (XYL) Could Be 23% Below Fair Value Following Its Q2 Profit Outlook Lift
Xylem (XYL) is back in focus after its Q2 FY2026 results showed stronger profitability. The company raised adjusted EPS guidance and improved its adjusted EBITDA margin outlook, despite trimming its full year revenue forecast. See our latest analysis for Xylem. Xylem's latest earnings update has arrived after a mixed share price run, with the stock at US$116.21 and a year to date share price return down 15.24%, while the 3 year total shareholder return of 19.86% contrasts with a 1 year total...
What Should Xylem (XYL) Investors Make Of Its New CFO And Board Pick?
Xylem (NYSE:XYL) appointed Andrea van der Berg as Chief Financial Officer and Executive Vice President. The company also added D. Christian Koch to its Board of Directors. These leadership changes highlight a refreshed focus on financial oversight and board-level experience. Leadership moves at Xylem keep attention on companies that prioritize resilient balance sheets and steadier earnings profiles, which makes it worth looking at a broader group of lower-risk stocks through 79 resilient...
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.